“Discovery consists of seeing what everyone has seen and thinking what nobody has thought”
Albert Szent-Györgyi (1893-1986), Biochemist & Nobel Prize Winner for Medicine in 1937
Whatever your application, we can supply you with a pack size for successful testing. And with no further preparation needed, you save on time and waste.
Our high-quality ISO 17025 and 17034 products come with extensive Certificates of Analysis containing measurement uncertainty values and can be used with pharmacopoeial methods and beyond.
lgcstandards.com/mikromol
mikromol@lgcgroup.com
Floor Plan
Conference Programme
Speaker Biographies
Plant Excursion
Vendor Profiles
The Events Group (TEG) is one of Europe’s leading business information providers. With two main services, business-to-business congresses, and professional trainings, we primarily focus on the key emerging markets in Central & Eastern Europe.
Our unique business-to-business congresses bring together senior-level executives from Europe’s largest organisations with a select and diverse group of cutting-edge suppliers. Strictly operating on an invitation-only basis guarantees the highest level of delegate is present.
Efficiency to the i stands for: innovation, integration, intuitive operation, and intelligent product design. Next-level of dust-tight machine design, system compatibility and digital connectivity.
With our complementary tableting tools and digital solutions, you can increase your efficiency even further.
fette-compacting.com
On behalf of TEG, we welcome you to the annual PHARM Connect Congress 2023, one of the largest pharmaceutical and biotechnology manufacturing events and the only regional one for Central and Eastern Europe in 2023.
The quality of the Congress is a direct result of its exclusivity. We have worked closely together with our programme advisory committee, leading local and regional associations and well-respected European and international media partners to ensure the event is of the highest quality and to guarantee its regional scope.
The Congress has been tailor-made for senior industry professionals to provide them with a platform which offers the most up-to-date market insights into R&D, production, engineering, logistics, purchasing and quality management-related topics along with innovative product and service presentations offered by leading local and international solution providers.
We are confident that our focused and targeted congress model will be a catalyst for your business success in one of the fastest-growing European regions in the pharmaceutical and biotechnology industries. Furthermore, we trust the PHARM Connect Congress will offer you the ideal networking opportunity to catch up on the latest developments and trends in your industry.
The TEG team wishes you a rewarding and fulfilling two days at the PHARM Connect Congress 2023 in Warsaw and we look forward to seeing you again at future TEG events.
Dennis Lantos Managing Director The Events Group
Katy Säurich Head of Operations & Production The Events Group
Exhibiton Area 2 nd floor – Grand Ballroom
Exhibiton Area 2 nd floor – Grand Ballroom Foyer
09:00 Doors open and event registration begins
TEG WELCOME ADDRESS:
Katy Säurich, Head of Production & Operations, TEG The Events Group
09:30-09:40
CHAIRMAN’S OPENING ADDRESS:
Dr. Christoph Herwig, Former Professor for Biochemical Engineering, Vienna University of Technology, Austria
CHAIRMAN’S OPENING PRESENTATION: Holistic Data Management & Digital Twins for Accelerated Product Life Cycle
• The product life cycle aims for efficient experimental design to obtain process knowledge and to make sure that process knowledge is transferable to manufacturing via smooth process validation
09:40-10:20
• Digital Twins are a key enabler to capture and deploy process knowledge. We show cases and scientific approaches to develop and deploy digital twins for multiple applications in biopharmaceutical processes
• Prerequisite for the shown approach is the holistic management of data of different frequencies and dimensionalities to obtain a contextualized data source
Dr. Christoph Herwig, Former Professor for Biochemical Engineering, Vienna University of Technology, Austria
10:20-10:40
Networking and Vendor Viewing
CASE-STUDY PRESENTATION: What makes a good Strategy for Outsourcing?
• How to shape outsourcing strategies and manage the transition using the example of a larger outsourcing project
10:40-11:20
• Resource-based view (RBV): Creating competitive advantage, risk management, efficiency gains, and change management strategies
• Importance of defining processes which avoid problems during the transfer of activities
Dr. Moritz Perscheid, Senior CMC Scientist, LGC Standards
11:20-11:40
Networking and Vendor Viewing
11:40-12:20
CASE-STUDY PRESENTATION:
Belupo’s Experience of Introducing a New Dosage Form into the Portfolio
– How to become a Medicated Foams Manufacturer
Preview of requirements a pharma company needs to take in mind when planning to become a manufacturer of a specific type of aerosol product, medicated foams:
• design of production area and liquid petroleum gas storage,
• procuration of specific manufacturing and process control equipment,
• setting up of critical safety measures, and
• establishing processes in line with GMP and Aerosol Directive requirements.
Ivana Kovač Lovrenčić, Head of R&D Pharmaceutical Technology Department & Small-Scale GMP Solid Dosage Forms Manufacturing, Belupo
12:20-13:20
Lunch and Vendor Viewing
CASE-STUDY PRESENTATION:
Drug Manufacturing during One Year of War – Impact on HR, Logistics, QA & RA
• Influence on Ukrainian pharmaceutical market: customer decrease & changing needs, reduced healthcare infrastructure, decrease in orders for local products due humanitarian aid, partial blackouts, stoppage of work during air alarms
13:20-14:00
– consequences for manufacturers, distributors, pharmacies and customers
• Staff is a main value for company’s sustainability during the war: corporative program for staff support
• Interaction & cooperation with DRA during the war
• Main results of 2022 and prospects for 2023 and beyond Dr. Sergii Sur, Director, Arterium
14:00-14:20
Networking and Vendor Viewing
CASE-STUDY PRESENTATION: Continues Processes in the Pharmaceutical Industry
• What is Continuous Manufacturing?
• Parallel granulation
• Continuous coater
14:20-15:00
• Multilotting
• Benefits of continuous processes
Sylwia Latoszewska, Process Support Unit Lead in Bulk Production, SANDOZ – A Novartis Division
Łukasz Lipiński, Process & OPEX Expert, SANDOZ – A Novartis Division
15:00-15:20
Networking and Vendor Viewing
15:20-16:00
CASE-STUDY PRESENTATION: Evolution of Real Time Monitoring
• What to look for in Real Time Monitoring Systems
• The Tive Solution including Proactive intervention in case of excursions
• Data Integration: The gain of partnering.
Alex Guillen, Global SME Life Science and Pharma, Tive
16:00-16:20
Networking and Vendor Viewing
CASE-STUDY PRESENTATION: Increase Analytical Throughput with Laboratory Workflow Automation
• Challenge of multi-platform analytical laboratories
• How to generate high throughput analytics by improving processes and combining assets
16:20-17:00
• Impact of process changes and improved analytical hardware
• Challenges of multi-attribute analysis on large sample sizes
• Difficulties of cell based bioanalytical method automation
• Accelerated small scale technology optimization
László Csuhaj, Head of Small Scale Biotechnology Development Laboratory, Biotechnology Business Unit, Gedeon Richter
17:00 Cocktail Reception
09:00 Door opening
CHAIRMAN’S OPENING ADDRESS:
09:30-09:40
Dr. Louis Boon, CSO & Management Board Member, JJP Biologics & Principal Scientific Advisor, Polpharma Biologics
CHAIRMAN’S OPENING KEYNOTE PRESENTATION: Discovery & Development of JJP-1212, the first Polish Developed Biological with Orphan Drug Designation
• Smart target selection
09:40-10:20
• Personalized medicine
• Preclinical package
• First-Human strategy
Dr. Louis Boon, CSO & Management Board Member, JJP Biologics & Principal Scientific Advisor, Polpharma Biologics
10:20-10:40
Networking and Vendor Viewing
PANEL DISCUSSION: CEE Innovation Panel - Academic-Science – Industry Collaboration in drug development
• How can collaboration between academia & the pharmaceutical industry be enhanced to drive innovation in CEE?
• In the context of the emerging role of science managers & specialized postgraduate studies, such as a Master’s in Science Administration: How can we effectively navigate the evolving landscape of cutting-edge pharmaceutical discoveries?
10:40-11:20
• How do we determine whether these breakthroughs are best suited for the business sector, academia, or at the intersection of both?
Introduction talk by: Dr. Magda Kordon, CEO & Founder, intoDNA
Marta Winiarska, President of the Board, Polish Union of Innovative Medical Biotech Companies BioInMed
Konrad Zawadzki, Deputy Director of the Biological and Chemical Research Center, University of Warsaw
Dr. Karolina Maria Nowak, Director of Innovation & Biotechnology Development Department, Medical Research Agency
11:20-11:40
Networking and Vendor Viewing
11:40-12:20
CASE-STUDY PRESENTATION:
Molecure, a pioneering clinical-stage biotech company striving to become a global leader in the discovery and development of groundbreaking small molecule drugs targeting unexplored protein and novel mRNA targets, with a focus on OATD-01 as a case study.
• Molecure, DNA, pipeline and key events
• Value generating programs
• OATD-01 history
• OATD-01 future
Dr. Marcin Szumowski, CEO, Molecure
12:20-13:20
Lunch and Vendor Viewing
CASE-STUDY PRESENTATION:
Targeting Apoptosis for Anticancer Therapy: Updates from Adamed’s Pipeline
• Apoptosis as a target for anticancer therapy
13:20-14:00
• Novel apoptosis inducing molecules in Adamed pipeline
• Proapoptotic fusion protein at a Pre-IND stage
• IND-ready MDM2 small molecule inhibitor program
Dr. Katarzyna Jastrzębska-Mazur, Scientific Program Manager, Preclinical Department, Adamed
14:00-14:20
Networking and Vendor Viewing
CASE-STUDY PRESENTATION:
Unlocking the Therapeutic Potential of Synthetic Lethality in Cancer Precision Medicine
• Overview of synthetic lethality and its relevance to cancer precision medicine
14:20-15:00
• Case studies of successful applications of synthetic lethality in preclinical and clinical settings, highlighting therapeutic benefits and potential limitations
• Presentation of projects from Ryvu pipeline in the area of synthetic lethality
• Future directions for synthetic lethality research, including the identification of novel discovery models, new biomarkers and therapeutic targets using 2D Prime platform
Dr. Krzysztof Brzozka, Chief Scientific Officer & Executive Vice President, Ryvu Therapeutics
15:00-15:20
Networking and Vendor Viewing
CASE-STUDY PRESENTATION: Me better and Me smart in IO Drug Development
15:20-16:00
• ‘me-better’ approach as a risk mitigation of project attrition
• ‘smart clinical trial design’ to create value infliction point in early clinical development
Dr. Pieter Spee, Chief Scientific Officer & Vice President of the Board of Directors, Pure Biologics
16:00
Dr. Louis Boon, CSO & Management Board Member, JJP Biologics & Principal Scientific Advisor, Polpharma Biologics
Christoph Herwig, bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at EPFL, Switzerland in bioprocess identification. Subsequently he positioned himself at the interface between bioprocess development and facility design in biopharmaceutical industry. Between 2008 – April 2023, he was a full professor for biochemical engineering at the Vienna University of Technology. His research area focused on the development of data science methods for integrated and efficient bioprocess development along PAT and QbD principles for biopharmaceuticals.
CSO &
Louis is the CSO and Management Board Member of JJP Biologics, an innovative new Polish company backed by the Starak family. JJP Biologics develops the next generation of novel therapeutic biologics around personalized medicine and companion diagnostics. Louis obtained his Ph.D. in Biochemistry at the University of Amsterdam. He was the founder of various companies focused on the generation and development of therapeutic monoclonal antibodies, primarily in the field of cancer and inflammation. In 2003, he was one of the founders of Bioceros BV, now Polpharma Biologics, where he currently holds the position of Principal Scientific Advisor. In addition, he held positions as CSO at MacroZyme BV, 4AZA Bioscience NV, FF Pharma, and VP preclinical for PanGenetics BV and Tanox. Louis is an author of over 340 publications in international scientific journals in the field of medical biotechnology and an inventor at more than 20 patent applications.
Moritz is an organic chemist and MBA by education. He received his PhD in chemistry from the University of Mainz for his work on strained, axial chiral allenyl lactams and he is a graduate of the Open University Business School. Moritz is a member of the EDQM working groups for excipients. At LGC Moritz has been leading the pharma services business for reference standards and served as strategic marketing manager. He gained significant experience in handling larger outsourcing projects which effect the organisation of departments.
and procurement and qualification of manufacturing equipment. She has also acquired advanced knowledge on GMP and ISO guideline implementation as a representative of small-scale solid dosage forms production. As a department head, she leads a small team of technicians and technologist dedicated to technological development of new generic products together with manufacture of smallscale commercial batches.
After work, Ivana enjoys doing DIY projects, travelling and spending active time in nature. She volunteers in a project for empowering young girls between 12 and 18 years of age.
Ivana Kovač Lovrenčić, M.Pharm. has been in Belupo Inc. since 2006, primarily working in R&D on formulation and process development, technology transfer and CTD Module 3 preparation for small molecule solid, semisolid and liquid dosage forms. Through the years she has gained broad experience working on different projects related to inhouse development, contractual development, regulatory applications, process improvement
Alex Guillen is an established executive with a proven record in global business and market development, with well-rounded experience in multicultural sales management and brand building. Alex has extensive experience and expertise in cold chain; as Director of Sales, Life Science and Pharma at Tive, Alex leads sales and business development within the company’s rapid-growth Life Science division. Previously, Guillen served as a Board Member and leader of Corporate Strategy at SWITRACE S.A, a developer of temperature and humidity data loggers compliant to the Pharma and Biotech industries. Alex’s extensive experience also includes serving as Global Cold Chain Director of Fisher Clinical Services, CEO of Escort Cold Chain Solutions SA, and Director for Commercial Operations for Novartis Vaccines.
Sylwia is a Manager, with 17 years of experience in working for the largest international pharmaceutical companies SANDOZ, ALCON in the area of quality, production, registration, logistics and distribution of medicinal products and medical device. Sylwia is a Certificate Coach ACTP IC, Certified internal and external auditor /GMP, ISO 9001, and ISO 13485. Currently, she works on the position of Process Support Unit Lead in Bulk Production and is responsible for managing a team of Experts, optimization production process according to LEAN and long horizons planning of investments and initiatives to increase the production capacity of our bulk production. After work, Sylwia is interested in psychology, modern management methods and personal development.
Dr Sur has over 30 years of work experience in the pharmaceutical sector, including 20 years in management positions. He received his PhD degree in Pharmacy and published over 100 scientific publications. Between 1993 and 1998 he was the Head of State Laboratory for Quality Control of Medicines at the Institute of Pharmacology and Toxicology at the Ukrainian Academy of Medical Sciences in Kyiv.
Between 1998 and 2005 he worked for the Ukraine Ministry of Health, firstly as the Director of Central Laboratory for Quality Control of Medicines and since 2000 as the Deputy State Chief Inspector for Quality Control of Medicines.
Magda founded intoDNA with a mission to make STRIDE the new standard in DNA damage analysis and enable DNA break detection at a new precision. She has authored the publication and the patent on DNA damage analysis with STRIDE. With more than a decade of research experience in biophysics and cell biology, she leads intoDNA and the STRIDE technology into new business verticals to support consistently growing numbers of customers in diagnosing DNA damage in yet new areas. Magda earned her PhD in Cell Biophysics from Jagiellonian University and was a visiting PhD student at UC Davis, Cold Spring Harbor Laboratory and UMass Medical School.
Since 2005, Dr Sur has been responsible for the development of a functional strategy in R&D and RA of ARTERIUM Corp.; the development and implementation of R&D and RA business processes and structure; and the organisation of research, development and marketing authorization of new products on all markets. Since 2018, Dr Sur is the Director of ARTERIUM LTD and a Member of Company Directors Board.
Additionally, Dr Sur is a member of the International Federation of Pharmacists (FIP) and since 1998 has been an adviser on International Pharmacopoeia and Pharmaceutical Preparations and since 2002 also on Traditional Medicines for the WHO which is headquartered in Geneva.
Łukasz Lipiński is a graduate of the Lodz University of Technology, Faculty of Organization and Management, majoring in Management and Production Engineering, specializing in Logistics in 2007.
He started his professional career while he was in college, working in the FMCG market at Coca-Cola HBC Polska Sp. z o.o company. He has gained professional experience in many positions for 6 years. He was mainly responsible for: calculation of logistics indicators, inventory control and cooperation with distribution companies
Then Łukasz started working in the company Leroy Merlin Polska Sp. z o.o., in which he was mainly responsible for optimizing the efficiency of warehouse processes and for cost and efficiency control of the Logistics Operator.
Currently he is gaining experience in the pharmaceutical market in the company Lek S.A. / Sandoz (Novartis group), where he has been working since 2014. Łukasz started working in the SCM department, then Continuous Improvement. He was responsible for administration and creation of logistics databases, lead optimization projects and spreading a design culture based on the methodology Lean Six Sigma.
Currently he is working as an OpEx and technology specialist on the production manufacture of tablets, where he acted as the Production Coordinator. He implements optimization projects and is responsible for the standardization of technological processes.
Marta Winiarska – lawyer, manager and expert in healthcare. A graduate of the law faculty (specialization in IP protection), as well as management postgraduate studies at the University of Warsaw and the Warsaw School of Economics.
For many years she is associated with economic and healthcare issues. She cooperated closely with Ministry of Development, Ministry of Foreign Affairs and Ministry of the Environment on projects aimed at the acceleration of startups and innovative SMEs and the international expansion of Polish entrepreneurs, including to Great Britain, China, Russia, Germany or the Czech Republic. She co-organized Polish American Innovation Week in California in 2014. For 5 years, she was responsible for public affairs and public relations in The Employers’ Union of Innovative Pharmaceutical Companies INFARMA, representing the organization in Parliament, at the Social Dialogue Council, industry conferences, media and in EFPIA.
From 2021, she took the position of president of the board of the Polish Union of Innovative Medical Biotech Companies BioInMed https:// bioinmed.pl
Konrad Zawadzki is the Deputy Director of the Biological and Chemical Research Center at the University of Warsaw since 2015. He manages the administrative units of the CNBCh UW and is responsible, among others, for the functioning of the scientific and research infrastructure of the Centre, core facility model included. He conducts commercialization processes at the CNBCh UW, including negotiations, signs contracts with external partners, facilitating science to business relations, i.a. working with biotech business.
Initially associated with the trade and logistics industry, then he coordinated activities related to the quality policy, implementing ISO, GMP, GHP, HACCP, BRC systems. He coordinated international projects both in terms of implementing new product lines and in terms of meeting safety standards. Panelist and expert of the EU training program in the field of entrepreneurship development. Quality expert of the Association of Polish Distributors and Exporters of Fruit and Vegetables “Fruit Union”. Participant of the delegation of the State Plant Health and Seed Inspection and the Ministry of Agriculture and Rural Development in China, Vietnam and the UAE as part of activities aimed at enabling the export of Polish fruit and vegetables to third country markets. Subsequently, the chairman of the Fruit and Vegetable Cluster, whose infrastructural goal was to build a modern laboratory for research on food safety.
As part of his activities at the University of Warsaw, he is the PM of the university -wide
projects, supporting the maintenance of the UW’s scientific and research infrastructure. A member of the Rector’s Council for Intellectual Property Management 2016-2020. Currently a member of the Senate of the University of Warsaw.
Dr Pieter Spee graduated as medical biologist/ biochemist and later specialized in immunology and oncology during his Ph.D. in Amsterdam. He worked at Novo Nordisk, where he went from a scientist dealing with cancer biology, angiogenesis, and immunology, through positions of principal investigator, project manager, up to Director of the NK cell biology department and then taking the position of Director and Scientific Director of the Department of Translational Immunology. At Novo Nordisk he took part in the development of Lirilumab and Monalizumab antibodies that are now in late-stage clinical development. He has served, among others, as CTO of FibroTX in Estonia (skin diagnostics), and CSO of Tikomed in Sweden (preclinical and clinical development of IBSOLVMIR for the improvement of pancreatic islet transplantation). He is a coinventor of 7 patents in the field of antibodies and has authored almost 30 scientific publications.
Head of Small Scale Biotechnology Development Laboratory, Biotechnology Business Unit, Gedeon Richter
László is a manager at Gedeon Richter pharmaceutical company with 11 years of biotechnology experience and a degree in chemistry and food engineering. He worked in various positions in the area of quality assurance, quality control, production and R&D. Currently, he works as the manager of small-scale biotechnology development and is responsible for managing a team of Experts, process and cell line performance optimization, development and validation of analytical and bioanalytical methods.
In his free time, László is interested in cultures and history, efficient management methods, reading scientific articles and books.
approved cardiac telemetry solution to the US and global market. He was also responsible for business development and oversaw the first products cleared for marketing in Europe and USA. Marcin co-founded and has been the lead investor in an early stage seed fund with a portfolio of 11 innovative life science companies and 2 successful exits. He has been a member of the GLG Institute and assisted the European Commission on independent expert panels performing the impact assessment and interim evaluations of the Innovative Medicines Initiative the world’s largest public-private partnership in pharmaceutical research.
Marcin is a serial life science entrepreneur and investor, who has over 20 years of experience in technology transfer, R&D project management and investments. He has been involved in preparation and management of more than 40 R&D and investment projects with a combined budget of over EUR 250 m. His previous company, Medicalgorithmics SA, was the first Polish ICT company to introduce an FDA-
Dr Karolina Nowak is director of the Department of Innovation and Biotechnology Development in Medical Research Agency.
She was a visiting scientist at Harvard Medical School, Dana-Farber Cancer Institute. She received a prestigious scholarship at Stanford University and did an Internship at Stanford Biomaterials and Advanced Drug Delivery Laboratory. Doctor Nowak is a graduate of Executive MBA at ESG University of Quebec at Montreal and Warsaw School of Economics. She is a patent inventor of new pharmaceutical drug formulation dedicated for patients with alveolar osteitis and she was a scientist in the field of Pharmaceuticals, drug formulations and molecular biology.
She has participated in numerous national and international projects. Beside her scientific activities she has experience in managing 2 commercial projects in area of drug development.
Dr. Brzozka is a highly accomplished Chief Scientific Officer at Ryvu Therapeutics, having joined the company in 2007. With his interdisciplinary expertise, he has played a pivotal role in building a robust pipeline of small molecule oncology therapeutics and a high throughput discovery engine platform. Dr. Brzozka is responsible for managing the early pipeline candidates, covering their full development until clinical phase, and he has brought two Ryvu first-in-class oncology programs into the clinic: dual PIM/FLT3 inhibitor SEL24/MEN1703 and SEL120, CDK8 inhibitor. He also sits on the board of Ardigen, a bioinformatics and precision medicine company, and played a key role in the founding of NodThera, a biotechnology company focused on therapeutics related to inflammasome biology.
Dr. Brzozka earned his Ph.D. degree from Ludwig Maximilian University and his MBA from the Stockholm University School of Business and the Krakow University of Economics Business School. He has contributed to over 70 scientific publications and presentations in areas of oncology, immunology, intracellular signaling, and medicinal chemistry. His publications have been cited nearly 3500 times and published in respected journals such as Science, Blood, Molecular Cell, and Oncotarget. Dr. Brzozka’s extensive experience and contributions have helped to advance the field of oncology and bring innovative therapies to patients.
Scientific Program Manager, Preclinical Department, Adamed
Katarzyna is a Scientific Program Manager and Principal Investigator in Adamed’s Innovative Department, where she is responsible for the development program of innovative anti-cancer biomolecules from lead optimization to IND/ CTA. She is a preclinical development expert specializing in toxicology studies and supports other programs of new and generic drugs in the area of non-clinical studies. Katarzyna’s educational background is in medical biotechnology, and her interests focus on cancer biology and cancer therapy. She graduated from Karol Marcinkiewicz Medical University of Poznan. She conducted her PhD research on recombinant silk protein carriers for anticancer drug delivery at the Greater Poland Cancer Centre in Poznan and Tufts University in Boston.
The congress also provides an opportunity to visit the Novartis Plant & Packaging Centre in Stryków, limited for 40 delegates and available on a first come first serve complimentary basis at 14:00 in the afternoon on 22nd May. This will last for approximately 2 hours and delegates will be split into two groups, 20 people joining a section focusing on production and quality and a further 20 comprising a group focusing on warehousing and packaging.
TRANSFER: The bus will leave from the front entrance of the Warsaw Marriott Hotel on 22nd May at 12:30 in the morning and will return after the visit at approximately 17:30.
Bulk unit in Strykow (BCS) is a modern, big scale facility production Centre focused on manufacturing of generic solid dosages drugs.
Facility opened in 2004 and originally planned for around 1billion tablets. Today, in the same foot print has an impressive capacity of over 10 billion.
BCS plays significant role in Novartis Technical Operations and supply two packaging facilities in Poland as well as customers in Canada, Slovenia, Germany and Asia market.
Innovative approach to mature generic products and fit to purpose and standardized equipment allows efficient manufacturing processes and as consequence very competitive costing for our customers and eventually for patients around the world. Current product portfolio concentrates around alimentary tract and metabolism (mostly metformin) and cardiovascular (bisoprolol, ramipril, torasemide, atorvastatin, rosuvastatin) and in the near future Combo Products sitagliptin+metformin.
Growing product portfolio and market demand for our products urges us to optimize current processes and target the continuous processes.
QUALITY:
Quality Unit consists of Quality Assurance and Quality Control. Quality Assurance teams are located according to main responsibilities –close to Production Unit for Operational QA and in the main office building for Quality Systems and Compliance.
Quality Control has QC laboratories in two locations. All our laboratories (chemical, microbiological and packaging material lab) are well equipped with modern techniques fulfilling data integrity requirements. In QC labs we test raw materials, API, finished products and packaging materials as well as environment. Central Testing Laboratory provides analytical testing services for other manufacturers in the scope of EU re-testing, stability testing and stability management. QC Lab is certified for Lean Lab management, supported with planning tools and continuous improvement. Next to QC team we have well-developed Analytical Science & Technology team responsible for analytical methods development, transfer, validation and equipment service. The design of the laboratories is compliant with GMP and HSE requirements.
In Stryków we operate two automated warehouses dedicated to: bulk and packaging operations. The first one with a capacity of 8,2 k pallets supports bulk operations and is used for handling and storage of APIs, excipients and bulk manufactured locally prior it is shipped to Packaging Centres. The second one, with 50% bigger capacity (13,5 k pallets), started its operations only in 2015, is dedicated to packaging and used
as a distribution warehouse for all products packed in Polish sites. Majority of its capacity is utilized by FDFs, the rest is consumed by primary and secondary packaging materials and bulk (both locally manufactured and imported from other suppliers). The warehouse and packaging operations are equipped with AGVs which ensure fully automated material between both operations. AGVs are also used on the production floor.
1. Total pallets shipped to customers (Finished Dosage Form) ~ 72 k, over 1300 trucks
2. Total pallets received ~ 27 k
3. Total number of pallet on stock ~19 k
Packaging Center in Stryków has been operating since 2015.
We are one of the largest Pharmaceutical packaging site in Poland. At our plant, we put operations safety first and the highest products quality. We operate on 15 highly automated packaging lines with potential to increase our capacity additionally up to 24 lines. We are growing 25% volumes every year. Our current production capacity is more than 9 billion tablets per year. We have innovative solutions in areas:
• robotization
• automatic material flow
• paperless production
• integrated support systems: MES, ERP, WMS, SCADA
• automatic washing and storage for format parts
WE INVITE YOU TO VISIT OUR PLANT!
Our Pharma Competence Centers ensure an uninterrupted cold chain with high safety standards and consistent quality control.
We provide unbroken cold chain service for the transport and storage of pharmaceutical products, with short transit times and constant temperature control for all goods between -70°C and +30°C.
Airportstrasse 9, Fischamend, Austria
Tel: +43 59 888-0
info@cargo-partner.com | www.cargo-partner.com
PRODUCT & SERVICE LISTING:
Cold Chain Packing, Storage & Distribution | Pharmaceutical Storage, Warehousing | Distribution | Courier, Express, Parcel | Freight Transport & Logistics Services: Air, Road
cargo-partner is a privately owned full-range info-logistics provider offering a comprehensive portfolio of air, sea, land transport and warehousing solutions. With 40 years of expertise in information technology and supply chain optimization, the company designs tailor-made services for a wide range of industries to create competitive benefits for its customers all around the world. Founded in 1983, cargo-partner generated a turnover of 1.8 billion euro in 2021, an estimated 2.05 billion euro in 2022 and currently employs 4,000 people worldwide. As an expert in handling pharmaceutical goods, cargo-partner offers hassle-free service for your healthcare logistics and provides unbroken cold chain service for the transport and storage of pharmaceutical products, with short transit times and constant temperature control for all goods between -70°C and +30°C.
Grabauer Strasse 24, 21493 Schwarzenbek, Germany
Tel: +49 41 51 120 tablet@fette-compacting.com | www.fette-compacting.com
Fette Compacting is with more than 5.000 installed machines the international market leader in the area of tablet presses in the pharmaceutical industry. The company has its headquarters in Schwarzenbek near Hamburg. A second technology and production facility is operated in Nanjing, China. Fette Compacting is represented in more than 50 countries worldwide.
PRODUCT & SERVICE LISTING:
Processing Machinery & Components: Tableting | Pharmaceutical Consultancy | Laboratory & Analytical Technology | Laboratory Equipment
The requirements on flexibility and efficiency in the production of pharmaceuticals and nutrition products are increasing fast. We offer integrated solutions for the entire production process. Tablet presses, capsule filling machines, tableting tools and process equipment. Plus extensive services, training offers and Performance Consulting.
Fette Compacting is a member of the LMT Group. This international, family-owned group of companies unites specialized manufacturers in the area of precision tool and special machinery construction.
Hamilton Bonaduz AG
Via Crusch 8, 7402 Bonaduz, Switzerland
Tel: +41 58 610 10 10 contact.pa.ch@hamilton.ch | www.hamiltoncompany.com
Sensor Systems for Bioprocess Monitoring
Hamilton process sensors are well known for high quality, long life, unique features, and competitive pricing. In order to meet these rigorous requirements, we are constantly striving to find new ways to design our sensors. As a result of the extensive work by our research and development department, Hamilton is able to offer outstanding solutions for pH, dissolved oxygen, dissolved carbon dioxide, cell density, conductivity and ORP monitoring.
Körber Pharma
Wulf-Werum-Str. 3, 21337 Lüneburg, Germany info.pasx@koerber.com www.koerber.com
Körber is an international technology group with about 12,000 employees, more than 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, Tissue and Technologies, we offer products, solutions and services that inspire.
PRODUCT & SERVICE LISTING:
Process Automation | Laboratory & Analytical Technology | Laboratory Equipment
PRODUCT & SERVICE LISTING:
Process Automation | Pharmaceutical Consultancy | IT for the Pharmaceutical Industry
At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world’s leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Intelligence Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value.
Cour lemaire 16, 4651 Battice, Belgium
Tel: + 32 87 32 40 50 info@iemps.com | www.iemps.com
PRODUCT & SERVICE LISTING:
Solutions for Biopharmaceuticals & Biologicals |
Plant Engineering & Maintenance |
OTHERS: Power Quality
IEM Power Systems develops and manufactures high reliability dynamic UPS (Uninterruptible Power Supplies) for critical applications including data centers, banks, governments, airports, hospitals, sensitive process industries, etc. IEM Power Systems is part of the Industrial Electric Mfg group (www.iemfg.com). The Rotabloc® RBT rotary uninterruptible power supply (RUPS) protects sensitive users from electrical disturbances coming from the mains, such as total power failures, micro-cuts, voltage drops and surges, slow voltage fluctuations, etc. It also improves the power quality of the installation by compensating the power factor, by rebalancing the phase currents and filtering harmonic currents generated by non linear loads.
ZA en Grain, 39360 MOLINGES, France
Tel: +33 384 414 200 jbtecnics@jbtecnics.com | www.groupejbt.com
PRODUCT & SERVICE LISTING:
Custom/ Contract Manufacturing | Drug Delivery Systems | Sterile Supplies | Packaging: Plastics | Pharmaceutical Consultancy
OTHERS: Injection Molding in Cleanrooms ISO7, Design and Manufacture of Tools, Assembling
EXPERT IN PLASTICS APPLICATIONS FOR THE MEDICAL & PHARMACEUTICAL MARKET
With almost 60 Years of experience in technical plastic parts market, GROUPE JBT can help you gain a strategic advantage by leading your projects in total confidentiality:
• R&D, design & conception of products and medical Devices
• Innovation platform: Patentability, market studies, CE marking
• Design & manufacture of tools (Prototype / multicavities / high productivity)
• Injection moulding in cleanrooms (ISO 7)
• Multicomponents injection, Overmoulding
• High tech equipments and robotization
• Laboratory of microbiologic controls
• Assembling (ISO 7 – ISO 8)
• Production plants: 4 in France, 1 in Mexico, 1 in Tunisia & 1 in Hungary
• Mechanical workshop in France
• Certifications: ISO 9001, ISO13485, ISO15378, GMP
JBT HUB UP alliance makes your project alive and drives it by providing more skills:
• Connected device, e-plastic…
• LSR, silicone injection/extrusion
• Design and construction of assembly machines, robotized systems, vision and controls.
LGC
ul. Ogrodowa 27/29 Kielpin, 05-092 Lomianki, Poland
Tel: +48 22 751 31 40 pl@lgcgroup.com | www.lgcstandards.com
PRODUCT & SERVICE LISTING:
Pharmaceuticals Ingredients: API’s, Excipients and fine chemicals | Custom/ Contract Manufacturing | Drug Delivery Systems | Pharmaceutical Consultancy | Outsourcing
LGC Standards is a division of LGC Group, the UK’s designated National Measurement Institute for chemical and bioanalytical measurements. We are a leading global manufacturer and service provider of quality assurance and research tools, supporting your analytical needs in more than 120 countries worldwide. We use our expertise to produce to the highest standard, including ranges accredited to ISO 17034. Our wide range of reference materials is complemented by our experience in outsourcing and customs, enabling us to adapt quickly to provide tailored solutions to meet your analytical needs.
The Mikromol difference, at a glance
• Robust internal quality control; including strict release criteria and continuous quality monitoring throughout lifecycle of standard, ISO accredited methodology, and homogeneity assessments.
• Comprehensive COAs ensuring excellent transparency and availability of results-from 100% mass balance to volatile contents, original spectra, chromatograms, and method details.
• Use of orthogonal methods to establish identity and assay, allowing quantitative use of the standard in any method being used in your laboratory.
• Adherence to GMP and GDP principles, as shown by our EXCiPACT® certification.
• Stringent packaging and labelling protocols, including low actinic pharmaceutical-grade, machine-controlled capping and Globally Harmonised
Raumedic develops solutions for life. Together with its customers, the medical technology company is breaking new ground to improve the diagnosis and treatment of diseases. In doing so, Raumedic focuses on polymer-based solutions for medical and pharmaceutical applications, as well as on products for intensive care.
Hermann-Staudinger-Str. 2, 95233 Helmbrechts, Germany
Tel: +49 9252 359 0 contact@raumedic.com | www.raumedic.com
As a partner of the international medical technology and pharmaceutical industry, Raumedic develops and produces customized components for customers, including tubing, catheters, and molded parts as well as complex groups of components and systems for a wide range of diagnostic and therapeutic uses. For the clinical areas of neuromonitoring and traumatology, Raumedic produces high-precision pressure-measurement sensors. The company is 100 percent family-owned.
Tiszatextil
8 Rue Decomble, 52000 Chaumont, France
Tel: +33 325 308 000 office_fr@tiszatextil.com | www.tiszatextil.com
TiszaTextil is the renown supplier of pharmaceutical logistic solutions which can replace cost-intensive investments in cleaning and transport systems. For existing transport processes we can also design advanced solutions with our customers. Based on our Minibags and pharmagrade pouches we can bring you astonishingly high ROI figures.
PRODUCT & SERVICE LISTING:
Pharmaceuticals Ingredients: Raw materials | Custom/ Contract Manufacturing | Drug Delivery Systems | Process Automation | Pharmaceutical Consultancy | Solutions for Biopharmaceuticals & Biologicals
PRODUCT & SERVICE LISTING:
Packaging: Plastics
OTHERS: Logistic solution
TiszaTexil wants to contribute to make Health accessible for all humans, so we support the Pharma industry with our cost saving solutions and easy to use and low maintenance products.
Besides that TiszaTextil plays also a major role in making the industrial bag business environmentally responsible and economically sustainable. Our single-material Pharma Minibags can be safely incinerated. No harmful chemicals are released, active substances are neutralized and the incineration generates energy. Their one-time use means no washing, so you avoid chemical pollution and save water too.
The safe, economical and eco-friendly transport solution for your pharma company. Go green with TiszaTextil Pharma Minibags!
PRODUCT & SERVICE LISTING:
500 Rutherford Ave, Suite 209, Boston MA 02129, USA
Tel: +1 617 631 8483 sales@tive.com | www.tive.com
Tive is a global leader in supply chain and logistics technology. With Tive, shippers, retailers, and logistics service providers (LSPs) have the ability to eliminate delays, avoid damage, and mitigate shipment failures. Tive’s solution provides insights generated by its industry-leading products for clients to actively optimize their shipments, improve customer experience, and unlock actionable data in real-time. For more information, visit www.tive.com.
Process Automation | Laboratory & Analytical Technology | IT for the Pharmaceutical Industry | Cold Chain Packing, Storage & Distribution | Freight Transport & Logistics Services: Air, Road
OTHERS: Supply Chain Monitoring
18-31
Tel: 001 (6464) 452 -4411 info@vimachem.com | www.vimachem.com
PRODUCT & SERVICE LISTING:
OTHERS: Manufacturing Operations Management (MoM), Manufacturing Execution Systems (MES), Serialization & Aggregation | Manufacturing Analytics & OEE, Electronic Batch Records (eBR), Digital Logbooks, Machine Connectivity, Professional Services
Vimachem’s Optimz Pharma 4.0 platform is a modern manufacturing execution system (MES) developed exclusively for the Pharma / Biotech industries that incorporates AI, IIoT, and Pharma 4.0 principles. The platform enables pharmaceutical and biotech companies to scale faster and with greater flexibility. Vimachem’s approach to manufacturing execution systems is fast to deploy and easy to use, with out-of-the-box connectivity to pre-built Vimachem Pharma 4.0 Intelligence MES apps. The platform also enables easy integration of all machines across pharma production and packaging shop floors. Vimachem’s deep expertise in pharmaceutical manufacturing operations ensures immediate ROI.
The Vimachem Pharma 4.0 Platform includes several key features, including a multi-tenant cloud platform that enables instant manufacturing analytics and insights from anywhere, digital Batch Records and Logbooks, digital document management (DMS) and guided workflows to support the workforce digitally during critical batch processes. The platform also offers a cutting-edge traceability software platform that enables compliance with global traceability standards while optimizing traceability operations.
Adam-Hoffmann-Straße 26, 67657 Kaiserslautern, Germany
Tel: +49 361 341 460 info@wipotec.com | www.wipotec.com
The Wipotec Group is a leading global provider of intelligent weighing and inspection technology.
Process Automation | Packaging Machinery & Equipment: Machinery and components, Labelling and RFID | Pharmaceutical Storage, Warehousing | Distribution
OTHERS: Track&Trace systems, Checkweighers, X-ray systems for pharma industry
Driven by our corporate philosophy “Innovation. Passion. First.”, we develop and produce unique machine solutions and technologies for OEM and end users in a wide range of industries at our head office in Kaiserslautern. As a founder-managed, solid company with 30 years of experience, we value enduring, long-term partnerships and always put our customers first. “First” as in top priority. Our integrated solutions come from “a single source” and extend along the entire value creation chain from hardware and software development to in-house production with a level of vertical integration exceeding 85% and after-sales service.
“Designed, engineered and manufactured in Germany” is a mark of premium quality and customer benefit derived in high-performance applications.
The Group’s success is due to the more than 1,000 employees who demonstrate their passion for technology to our customers on a daily basis.
Two global sales and service companies with over 100 branch offices and distribution partners operate under the umbrella of the Wipotec Group.
With a broad portfolio of checkweighers, X-ray machines, Track & Trace products and innovative systems for the mail and logistics industry, Wipotec serves our global retail business in nine target industries. Wipotec is the global leader in the integration of EMFR Weigh Cells and kits and, as a result, offers our OEM customers significant competitive advantages.
Glebowa 10 street, Warsaw 02-988, Poland
Tel: +48 7250 040 05 | biuro@coleman.pl www.coleman.pl | www.systechone.com
Systech provides digital identification and traceability solutions that establish essential product data, ensure digital connectivity and enable real-time insights on the packaging line and throughout the supply chain. With decades of experience in pharmaceutical packaging execution and serialization, Systech offers comprehensive, easily configured, turnkey software solutions with reliable implementation and expert support.
Official
PRODUCT & SERVICE LISTING:
Process Automation | Packaging Machinery & Equipment: Machinery and components, Labelling and RFID | Auto ID & Mobility solutions: Brand Protection, Anti-Counterfeiting | IT for the Pharmaceutical Industry
OTHERS: Track and Trace, Serialization, Identification and traceability systems, Product authentication
Global brands across industries rely on Systech’s platform to help them achieve their objectives in compliance, brand protection, resiliency and digital transformation. Systech is a leading brand of Markem-Imaje®, a global product identification, packaging intelligence and connected product solutions provider. Coleman International focuses on providing marking and coding solutions for industrial applications for Cosmetic, Pharma, Automotive, Extrusion and Electronic sectors.
Coleman is a partner of Markem-Imaje and SYSTECH companies, global leaders in marking and coding systems, providing authentication and identification software, that secures traceability and monitoring products in supply chain.
Through 30 years of experience in Polish market, delivering and integrating identification systems as well providing aftersales support with consumables and services, Coleman established professional, skilled sales and engineering team for expertise on complex integration of hardware and software solutions, enabling automation and synchronization of marking and coding processes that are crucial for innovative factory.
Systech dostarcza cyfrowe rozwiązania w zakresie identyfikacji i monitorowania, które ustalają podstawowe dane dotyczące produktu, zapewniają łączność cyfrową i umożliwiają wgląd w czasie rzeczywistym na linii pakującej i w całym łańcuchu dostaw. Dzięki wieloletniemu doświadczeniu w produkcji i serializacji opakowań farmaceutycznych, Systech oferuje kompleksowe, łatwe w konfiguracji, gotowe rozwiązania oprogramowania wraz z niezawodną implementacją i wsparciem ekspertów.
Globalne marki z różnych branż polegają na platformie Systech, która pomaga im osiągnąć cele w zakresie zgodności z przepisami, ochrony marki, odporności na zakłócenia procesów i transformacji cyfrowej. Systech jest wiodącą marką firmy Markem-Imaje®, globalnego dostawcy systemów do identyfikacji produktów, analizy procesów pakowania oraz rozwiązań dla produktów połączonych.
Coleman International koncentruje się na dostarczaniu rozwiązań do znakowania i kodowania do zastosowań przemysłowych w branży kosmetycznej, farmaceutycznej, motoryzacyjnej, kablowej oraz elektronicznej. Coleman jest partnerem firm Markem-Imaje i SYSTECH, światowych liderów systemów znakowania i kodowania, dostarczających oprogramowanie do uwierzytelniania i identyfikacji, które zabezpiecza identyfikowalność i monitorowanie produktów w całym łańcuchu dostaw.
Dzięki 30-letniemu doświadczeniu na polskim rynku w dostarczaniu i integracji systemów identyfikacji oraz obsłudze posprzedażowej w zakresie materiałów eksploatacyjnych i usług serwisowych, Coleman stworzył profesjonalny, wykwalifikowany zespół handlowo-inżynierski, który zajmuje się kompleksową integracją rozwiązań sprzętowych i softwarowych, umożliwiających automatyzację i synchronizację procesów znakowania i kodowania, które są kluczowe dla innowacyjnej fabryki.
Zetaplatz 1, 8501 Lieboch, Austria
Tel: +43 3136 9010 1000 office@zeta.com | www.zeta.com/en
Processing Machinery & Components: Blending, Filtration, Mixing | Process Automation | Pharmaceutical Consultancy | Solutions for Biopharmaceuticals & Biologicals | Clean rooms & Accessories: Validation | Plant Engineering & Maintenance
OTHERS: Integrated Engineering, Decarbonization for the Pharmaceutical Industry, Automation Solutions
The ZETA Group, with 1200 highly qualified employees and 27 subsidiaries worldwide, specializes in planning, automation, digitalization and qualification of customized biopharmaceutical facilities for aseptic process solutions. ZETA acts as an end-to-end solution provider, combining plant engineering with HVAC and cleanroom design. Biopharmaceutical active ingredients, such as anticancer drugs, insulin, vaccines and infusions are produced in these highly complex, “tailor-made” facilities. ZETA supports its customers along the entire drug development and manufacturing pathway with sophisticated solutions from laboratory to industrial production scale. Through its Smart Engineering Services, ZETA creates digital twins of process plants and has thus established itself as a market leader for digital solutions in the pharmaceutical and biotech industry.
ZETA is also actively taking steps towards a more sustainable future for the industry as a whole: through ZETA’s decarbonization strategies, emissions are specifically reduced during the biopharmaceutical manufacturing process.
PHARMACEUTICALS
Raw mateRials
RAUMEDIC AG
aPi’s
LGC exciPients and fine chemicals
LGC
CUSTOM/ CONTRACT MANUFACTURING
JBT
LGC
Raumedic AG
PROCESSING MACHINERY & COMPONENTS
Blending
ZETA GmbH
filtRation
ZETA GmbH
mixing
ZETA GmbH
taBleting
Fette Compacting GmbH
DRUG DELIVERY SYSTEMS
JBT
LGC
Raumedic AG
PROCESS AUTOMATION
Coleman International Sp. z o.o. / SYSTECH
Hamilton Bonaduz AG
Körber Pharma
Raumedic AG
Tive
WIPOTEC GmbH
ZETA GmbH
STERILE SUPPLIES
JBT
PACKAGING
Plastics
JBT
Tiszatextil Packaging SAS
SOLUTIONS FOR BIOPHARMACEUTICALS & BIOLOGICALS
IEM Power Systems
Raumedic AG
ZETA GmbH
PHARMACEUTICAL CONSULTANCY
Fette Compacting GmbH
JBT
Körber Pharma
LGC
Raumedic AG
ZETA GmbH
LABORATORY & ANALYTICAL TECHNOLOGY
Fette Compacting GmbH
Hamilton Bonaduz AG
Tive
LABORATORY EQUIPMENT
Fette Compacting GmbH
Hamilton Bonaduz AG
PACKAGING MACHINERY & EQUIPMENT
machineRy and comPonents
Coleman International Sp. z o.o. / SYSTECH
WIPOTEC GmbH
laBelling and Rfid
Coleman International Sp. z o.o. / SYSTECH
WIPOTEC GmbH
AUTO ID & MOBILITY SOLUTIONS
BRand PRotection, anti-counteRfeiting
Coleman International Sp. z o.o. / SYSTECH
IT FOR THE PHARMACEUTICAL INDUSTRY
Coleman International Sp. z o.o. / SYSTECH
Körber Pharma
Tive
CLEAN ROOMS & ACCESSORIES
Validation
ZETA GmbH
PLANT ENGINEERING & MAINTENANCE
IEM Power Systems
ZETA GmbH
COLD CHAIN PACKING, STORAGE & DISTRIBUTION
cargo-partner GmbH
Tive
OUTSOURCING
LGC
PHARMACEUTICAL STORAGE, WAREHOUSING
cargo-partner GmbH
WIPOTEC GmbH
DISTRIBUTION
cargo-partner GmbH
WIPOTEC GmbH
COURIER, EXPRESS, PARCEL
cargo-partner GmbH
FREIGHT TRANSPORT & LOGISTICS SERVICES
aiR
cargo-partner GmbH
Tive
Road
cargo-partner GmbH
Tive
OTHERS:
PoweR Quality
IEM Power Systems
injection molding in cleanRooms iso7
JBT
design and manufactuRe of tools
JBT
tRack and tRace, seRialization, identification and tRaceaBility systems, PRoduct authentication
Coleman International Sp. z o.o. / SYSTECH
logistic solution
Tiszatextil Packaging SAS
suPPly chain monitoRing
Tive
manufactuRing
oPeRations management (mom), manufactuRing execution systems (mes), seRialization & aggRegation
Vimachem
integRated engineeRing, decaRBonization foR the PhaRmaceutical industRy, automation solutions
ZETA GmbH
manufactuRing analytics & oee, electRonic Batch RecoRds (eBR), digital logBooks, machine connectiVity, PRofessional seRVices
Vimachem
tRack&tRace systems, checkweigheRs, x-Ray systems foR PhaRma industRy
WIPOTEC GmbH
ww w .pha rmc onn ect e u
CE NTR A L & E AS TER N EURO P E ’ S
LE A D ING B2B N E T W ORK ING EVE N T F
T E G The E vents Grou p Lt d.
Tel: + 3 6 1 2 1 9 5 7 2 5 | Fax: +3 6 1 2 1 9 5 7 2 6 11 3 7 B udapest, R adnóti u 2 ., Hunga r y ww w.tegeve n t s .eu | info@tege v ent s. eu
T E G T he E ve nts
G r o up i s o ne o f Europ e ’s l ead i n g bus ness nf o rm a t on pr ovi d e rs o p e r a t i n g pri m ar l y wi th i n the k e y e m e rg ng m a rk e ts o f C e ntr al and E a st e rn Europ e T he ma n f oc us i s o n bus i n e ss-to - bus i n e ss co ngr e ss e s that c onne c t t o p pr o f e ss io na l s wi th i n va r io us ndustri e s n th e reg io n, br i ng n g to ge ther sen io r exe cut ive s from Europe ’s l argest co mp a n ie s wi th e a d i ng s e r vic e pr ovi d e rs.
4 22-23 NOVEMBER
ww w tr an sl o gc onn ect e u
CE NTR A L & E AS TER N EURO P E ’ S LE A D ING B2B N E T W ORK ING EVE N T